Gerhard Ehninger, M.D.^1,2, Sabrina Kraus^3*, Elisa Sala, MD^4*, Stephan K Metzelder, MD^5*, Vladan Vucinic, MD^6*, Walter Fiedler, MD⁷, Maria-Elisabeth Goebeler, MD^8*, Jan Moritz Middeke, MD^9*, Malte von Bonin, MD^10*, Carla Kreissig^11*, Jan Koedam, MSc^12*, Marc Cartellieri, Ph.D.^13*, Armin Ehninger^14*, Martin Wermke, MD^15* and Jonas A. Schäfer, MD^16*

¹AvenCell Europe GmbH, Dresden, Germany
²Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus der TU Dresden, Dresden, Germany
³University Hospital of Wurzburg, Wurzburg, DEU
⁴Klinik fuer Innere Medzin III, Bone Marrow Transplantation Unit, University Hospital of Ulm, Ulm, Germany
⁵Dep. of Internal Medicine, Hematology, Oncology and Immunology, Philipps University Marburg and University Hospital Giessen and Marburg, Campus Marburg, Marburg, Germany
⁶Department for Hematology, Cell Therapy and Hemostaseology, University of Leipzig Medical Center, Leipzig, Germany
⁷Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, University Cancer Center Hamburg, University Hospital Eppendorf, Hamburg, Germany
⁸Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg, Germany
⁹Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany
¹⁰Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Saxony, Germany
¹¹Cellex manufacturing Transport and Logistics GmbH, Köln, NRW, DEU
¹²AvenCell Therapeutics inc, Dresden, Saxony, Germany
¹³Cellex Patient Treatment GmbH, Dresden, Germany
¹⁴AvenCell Therapeutics inc., Dresden, Germany
¹⁵Medical Faculty, NCT/UCC Early Clinical Trial Unit, Technical University Dresden, Dresden, Germany
¹⁶Department of Hematology, Oncology and Immunology, University hospital Gießen and Marburg, Marburg, Germany

Xian Zhang^1,2, Junfang Yang^1,2*, Jingjing Li^1,2*, Liyuan Qiu^2*, Jianqiang Li, PhD³ and Peihua Lu, MD^1,2

¹Beijing Lu Daopei Institute of Hematology, Beijing, China
²Hebei Yanda Lu Daopei Hospital, Langfang, China
³Hebei Senlang Biotechnology Co., Ltd., Shijiazhuang, Hebei, China

David A. Sallman, MD¹, Daniel J. DeAngelo, MD, PhD², Naveen Pemmaraju, MD³, Shira Dinner, MD⁴, Saar Gill, MD, PhD⁵, Rebecca L. Olin, MD⁶, Eunice S. Wang, MD⁷, Marina Konopleva, MD, PhD⁸, Eileen Stark, MSN, CPNP^9*, Ana Korngold, PhD^9*, Asifa Haider, PhD^9*, Kate Backhouse, BSc^9*, Carolyn Figliola, BS^9*, Daniel J. Lee, MD⁹, Mark G. Frattini, MD, PhD⁹, Carrie Brownstein, MD⁹ and Gail J. Roboz, MD¹⁰

¹Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
²Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
³Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
⁵Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
⁶University of California, San Francisco, San Francisco, CA
⁷Leukemia Service, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
⁸MD Anderson Cancer Center, Houston, TX
⁹Cellectis, Inc., New York, NY
¹⁰Division of Hematology and Oncology, Weill Cornell Medicine and The New York-Presbyterian Hospital, New York, NY

Nikeshan Jeyakumar, MD¹, Sneha Ramakrishna, MD², Matthew J Frank, MD, PhD³, Bita Sahaf, PhD^4*, Steven A. Feldman, PhD^4*, David B. Miklos, MD, PhD⁵, Crystal L. Mackall, MD⁶, Kara L. Davis, D.O.⁷, Lori Muffly, MD, MS⁸ and Liora M. Schultz, MD⁹

¹Department of Medicine, Divisions of Hematology and Oncology, Stanford University School of Medicine, Stanford, CA
²Department of Pediatrics, Division of Hematology and Oncology, Stanford University School of Medicine, Stanford, CA
³Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Palo Alto, CA
⁴Center for Cancer Cell Therapy, Stanford University School of Medicine, Stanford, CA
⁵Division of BMT and Cellular Therapy, Stanford University, Stanford, CA
⁶Divisions of Hematology and Oncology, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA
⁷Department of Pediatrics, Hematology, Oncology, and Stem Cell Transplant and Regenerative Medicine, Stanford University, Stanford, CA
⁸Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA
⁹Department of Pediatrics, Division of Hematology and Oncology, Stanford University School of Medicine, Palo Alto, CA

Regina M. Myers, MD¹, Amanda M. DiNofia, MD, MSCE^1*, Yimei Li, PhD^2*, Caroline Diorio, MD¹, Richard Aplenc, MD, PhD¹, Diane Baniewicz, MSN, CRNP^1*, Jennifer L Brogdon, PhD³, Colleen Callahan, MSN, CRNP^1*, Boris Engels, PhD^3*, Joseph A. Fraietta, PhD^4*, Vanessa Gonzalez, MBA^4*, Emma Iannone, BS^1*, Allison Barz Leahy, MD, MSCE^1*, Hongyan Liu, PhD^2*, Susan E. McClory, MD, PhD⁵, Susan R. Rheingold, MD¹, Laura Shinehouse, BA^1*, Gerald Wertheim, MD, PhD⁶, Lisa Wray, MD^1*, Noelle V. Frey, MD, MS⁷, Shannon L. Maude, MD¹ and Stephan A. Grupp, MD, PhD¹

¹Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
²Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA
³Novartis Institutes for BioMedical Research, Cambridge, MA
⁴Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
⁵Division of Oncology, Children's Hospital of Philadelphia, Havertown, PA
⁶Department of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA
⁷Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA

David M. Kurtz, MD, PhD¹, Sairah Ahmed, MD², Cheuk Ka Tong^3*, Matthew Mei, MD⁴, Cliff Ding, PhD^3*, Ian W. Flinn, MD PhD⁵, Peter A. Riedell, MD⁶, Gregory J. Hogan, PhD^7*, Andre Schultz, PhD^7*, Jacob J. Chabon, PhD^7*, Helen E. Heslop, MD, DSc (Hon)⁸, Aung Myo, MD^3*, Ash A. Alizadeh, MD, PhD⁹ and Ivan D. Horak, MD³

¹Stanford University, Palo Alto, CA
²Department of Lymphoma/Myeloma and Stem Cell Transplantation, The University of Texas M D Anderson Cancer Center, Houston, TX
³Tessa Therapeutics, Singapore, Singapore
⁴Division of Lymphoma, City of Hope Medical Center, Duarte, CA
⁵Tennessee Oncology, Sarah Cannon Research Institute, Nashville, TN
⁶Section of Hematology/Oncology, University of Chicago, Chicago, IL
⁷Foresight Diagnostics, Aurora, CO
⁸Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX
⁹Stanford University, Stanford, CA